1. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 71(3), 209–249.
2. Petrick, J. L., Florio, A. A., Znaor, A., Ruggieri, D., Laversanne, M., Alvarez, C. S., Ferlay, J., Valery, P. C., Bray, F., & McGlynn, K. A. (2020). International trends in hepatocellular carcinoma incidence, 1978–2012. International journal of cancer, 147(2), 317–330.
3. Yu, S. J. (2016). A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clinical and MolecularHepatology, 22(1), 7–17.
4. Grandhi, M. S., Kim, A. K., Ronnekleiv-Kelly, S. M., Kamel, I. R., Ghasebeh, M. A., & Pawlik, T. M. (2016). Hepatocellular carcinoma: From diagnosis to treatment. Surgical Oncology, 25(2), 74–85.
5. Zhang, W., Zhang, B., & Chen, X. P. (2021). Adjuvant treatment strategy after curative resection for hepatocellular carcinoma. Frontiers of Medicine, 15(2), 155–169.